Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Adel Mandl, Mark C. Markowski, Michael A. Carducci & Emmanuel S. Antonarakis. (2023) Role of bromodomain and extraterminal (BET) proteins in prostate cancer. Expert Opinion on Investigational Drugs 32:3, pages 213-228.
Read now
Read now
Eric S. Christenson & Emmanuel S. Antonarakis. (2018) PARP inhibitors for homologous recombination-deficient prostate cancer. Expert Opinion on Emerging Drugs 23:2, pages 123-133.
Read now
Read now
Mark C. Markowski, Angelo M. De Marzo & Emmanuel S. Antonarakis. (2017) BET inhibitors in metastatic prostate cancer: therapeutic implications and rational drug combinations. Expert Opinion on Investigational Drugs 26:12, pages 1391-1397.
Read now
Read now
Articles from other publishers (21)
Giovanni Maria Iannantuono, Elias Chandran, Charalampos S. Floudas, Hyoyoung Choo-Wosoba, Gisela Butera, Mario Roselli, James L. Gulley & Fatima Karzai. (2023) Efficacy and safety of PARP inhibitors in metastatic castration-resistant prostate cancer: A systematic review and meta-analysis of clinical trials. Cancer Treatment Reviews 120, pages 102623.
Crossref
Crossref
Fidelis Charles Bugoye, Rispah Torrorey-Sawe, Richard Biegon, Nazima Dharsee, Fidelice M. S. Mafumiko, Kirtika Patel & Simeon K. Mining. (2023) Mutational spectrum of DNA damage and mismatch repair genes in prostate cancer. Frontiers in Genetics 14.
Crossref
Crossref
Xianzhe Yu, Lingling Zhu, Ting Wang, Lu Li, Jiewei Liu, Guowei Che & Qinghua Zhou. (2023) Enhancing the anti-tumor response by combining DNA damage repair inhibitors in the treatment of solid tumors. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1878:4, pages 188910.
Crossref
Crossref
Tomas Januskevicius, Rasa Sabaliauskaite, Daiva Dabkeviciene, Ieva Vaicekauskaite, Ilona Kulikiene, Agne Sestokaite, Asta Vidrinskaite, Arnas Bakavicius, Feliksas Jankevicius, Albertas Ulys & Sonata Jarmalaite. (2023) Urinary DNA as a Tool for Germline and Somatic Mutation Detection in Castration-Resistant Prostate Cancer Patients. Biomedicines 11:3, pages 761.
Crossref
Crossref
Gunhild von Amsberg, Mirjam Zilles, Wael Mansour, Philipp Gild, Winfried Alsdorf, Moritz Kaune, Lukas Böckelmann, Jessica Hauschild, Christoph Krisp, Tina Rohlfing, Ceren Saygi, Malik Alawi, Alexandra Zielinski, Claudia Langebrake, Su Jung Oh-Hohenhorst, Sven Perner, Derya Tilki, Hartmut Schlüter, Markus Graefen, Sergey A. Dyshlovoy & Carsten Bokemeyer. (2022) Salvage Chemotherapy with Cisplatin, Ifosfamide, and Paclitaxel in Aggressive Variant of Metastatic Castration-Resistant Prostate Cancer. International Journal of Molecular Sciences 23:23, pages 14948.
Crossref
Crossref
Bilal Abdi, Noemie Basset, Emmanuel Perrot, Marc‐Antoine Benderra, Ahmed Khalil, Stephane Oudard, Pascal Blanchet, Laurent Brureau, Florence Coulet, Olivier Cussenot & Geraldine Cancel‐Tassin. (2022) DNA damage repair gene germline profiling for metastatic prostate cancer patients of different ancestries. The Prostate 82:12, pages 1196-1201.
Crossref
Crossref
Antonio Giovanni Solimando, Charis Kalogirou & Markus Krebs. (2022) Angiogenesis as Therapeutic Target in Metastatic Prostate Cancer – Narrowing the Gap Between Bench and Bedside. Frontiers in Immunology 13.
Crossref
Crossref
Rajendra Kumar, Janet Mendonca, Olutosin Owoyemi, Kavya Boyapati, Naiju Thomas, Suthicha Kanacharoen, Max Coffey, Deven Topiwala, Carolina Gomes, Busra Ozbek, Tracy Jones, Marc Rosen, Liang Dong, Sadie Wiens, W. Nathaniel Brennen, John T. Isaacs, Angelo M. De Marzo, Mark C. Markowski, Emmanuel S. Antonarakis, David Z. Qian, Kenneth J. Pienta, Drew M. Pardoll, Michael A. Carducci, Samuel R. Denmeade & Sushant K. Kachhap. (2021) Supraphysiologic Testosterone Induces Ferroptosis and Activates Immune Pathways through Nucleophagy in Prostate Cancer. Cancer Research 81:23, pages 5948-5962.
Crossref
Crossref
Zachary S. Dovey, Sujit S. Nair, Dimple Chakravarty & Ashutosh K. Tewari. (2021) Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies. Cancer Reports 4:5.
Crossref
Crossref
Chiara Pisano, Marcello Tucci, Rosario Francesco Di Stefano, Fabio Turco, Giorgio Vittorio Scagliotti, Massimo Di Maio & Consuelo Buttigliero. (2021) Interactions between androgen receptor signaling and other molecular pathways in prostate cancer progression: Current and future clinical implications. Critical Reviews in Oncology/Hematology 157, pages 103185.
Crossref
Crossref
Pedro Isaacsson Velho, Fahad Qazi, Sayeedul Hassan, Michael A. Carducci, Samuel R. Denmeade, Mark C. Markowski, Daniel L. Thorek, Theodore L. DeWeese, Daniel Y. Song, Phuoc T. Tran, Mario A. Eisenberger & Emmanuel S. Antonarakis. (2019) Efficacy of Radium-223 in Bone-metastatic Castration-resistant Prostate Cancer with and Without Homologous Repair Gene Defects. European Urology 76:2, pages 170-176.
Crossref
Crossref
Ramy Sedhom & Emmanuel S Antonarakis. (2019) Clinical implications of mismatch repair deficiency in prostate cancer. Future Oncology 15:20, pages 2395-2411.
Crossref
Crossref
Catherine Handy Marshall, Wei Fu, Hao Wang, Alexander S. Baras, Tamara L. Lotan & Emmanuel S. Antonarakis. (2018) Prevalence of DNA repair gene mutations in localized prostate cancer according to clinical and pathologic features: association of Gleason score and tumor stage. Prostate Cancer and Prostatic Diseases 22:1, pages 59-65.
Crossref
Crossref
Philipp Nuhn, Johann S. De Bono, Karim Fizazi, Stephen J. Freedland, Maurizio Grilli, Philip W. Kantoff, Guru Sonpavde, Cora N. Sternberg, Srinivasan Yegnasubramanian & Emmanuel S. Antonarakis. (2019) Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology. European Urology 75:1, pages 88-99.
Crossref
Crossref
Maria I. CarloVeda N. GiriChanning J. PallerWassim AbidaJoshi J. AlumkalTomasz M. BeerHimisha BeltranDaniel J. GeorgeElisabeth I. HeathCelestia S. HiganoRana R. McKayAlicia K. MorgansAkash PatnaikCharles J. RyanEdward M. SchaefferWalter M. StadlerMary-Ellen TaplinNoah D. KauffJacob VinsonEmmanuel S. AntonarakisHeather H. Cheng. (2018) Evolving Intersection Between Inherited Cancer Genetics and Therapeutic Clinical Trials in Prostate Cancer: A White Paper From the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium. JCO Precision Oncology:2, pages 1-14.
Crossref
Crossref
Pasquale Rescigno, Robert Chandler & Johann de Bono. (2018) Relevance of poly (ADP-ribose) polymerase inhibitors in prostate cancer. Current Opinion in Supportive & Palliative Care 12:3, pages 339-343.
Crossref
Crossref
Emmanuel S. Antonarakis, Changxue Lu, Brandon Luber, Chao Liang, Hao Wang, Yan Chen, John L. Silberstein, Danilo Piana, Zhao Lai, Yidong Chen, William B. Isaacs & Jun Luo. (2018) Germline DNA-repair Gene Mutations and Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Receiving First-line Abiraterone and Enzalutamide. European Urology 74:2, pages 218-225.
Crossref
Crossref
Emmanuel S Antonarakis. (2018) Abiraterone plus olaparib in prostate cancer: a new form of synthetic lethality?. The Lancet Oncology 19:7, pages 860-861.
Crossref
Crossref
Karim Boudadi, Daniel L. Suzman, Valsamo Anagnostou, Wei Fu, Brandon Luber, Hao Wang, Noushin Niknafs, James R. White, John L. Silberstein, Rana Sullivan, Donna Dowling, Rana Harb, Thomas R. Nirschl, Brendan A. Veeneman, Scott A. Tomlins, Yipeng Wang, Adam Jendrisak, Ryon P. Graf, Ryan Dittamore, Michael A. Carducci, Mario A. Eisenberger, Michael C. Haffner, Alan K. Meeker, James R. Eshleman, Jun Luo, Victor E. Velculescu, Charles G. Drake & Emmanuel S. Antonarakis. (2018) Ipilimumab plus nivolumab and DNA-repair defects in AR-V7-expressing metastatic prostate cancer. Oncotarget 9:47, pages 28561-28571.
Crossref
Crossref
Pedro Isaacsson Velho, John L. Silberstein, Mark C. Markowski, Jun Luo, Tamara L. Lotan, William B. Isaacs & Emmanuel S. Antonarakis. (2018) Intraductal/ductal histology and lymphovascular invasion are associated with germline DNA‐repair gene mutations in prostate cancer. The Prostate 78:5, pages 401-407.
Crossref
Crossref
George J. Netto, Marie-Lisa Eich & Sooryanarayana Varambally. (2017) Prostate Cancer: An Update on Molecular Pathology with Clinical Implications. European Urology Supplements 16:12, pages 253-271.
Crossref
Crossref